drugset / Trial / NCT00560079

Efficacy of Allopurinol and Dypiridamole in Acute Mania

NCT00560079

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to evaluate the potential antimanic efficacy, safety and tolorability of the purinergic agents allopurinol and dipyridamole as an add-on treatment to lithium in a sample of 180 drug-free manic patients enrolled in a double-blind, placebo-controlled design.

Timeline

Start
2003-11
Primary completion
2005-04
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Allopurinol Small molecule 600 mg Oral
Comparator Dipyridamole Other / unclassified 200 mg Oral